AMY COSMA: Open Payments
NPI 1245865252 · BRISTOL, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 4 payments from 3 companies in 2025. Trend: 2023 $1,011 · 2024 $816 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $233 |
| Otsuka America Pharmaceutical, Inc. | 1 | $109 |
| ABBVIE INC. | 1 | $19 |
Products named: UZEDY, AUSTEDO XR, REXULTI, VRAYLAR.
Industry payments across RI — which companies pay providers there.
